MedTrace Logo

Adductor Canal Block After Total Knee Replacement - a Suture-method Catheter vs a Standard Catheter vs a Single Bolus

NCT03142789 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 153

Last updated 2018-05-01

No results posted yet for this study

Summary

In this study we wish to investigate the analgesic effect of the administration of 0.2% ropivacaine for an adductor canal block as repeated boluses (20 ml every 8 hours) through a new suture-method catheter or a standard perineural catheter compared with a single bolus (20 ml), in patients following primary total knee arthroplasty.

Conditions

  • Pain Management

Interventions

DRUG

Initial bolus (Certa and standard catheter groups)

10 ml of ropivacaine 0,75% will be used to ensure correct position of the needle and to expand the adductor canal, followed by injection of another 10 ml of ropivacaine 0.75% via the catheter during real time US imaging to ensure correct placement of the catheter.

DRUG

Initial bolus (Single bolus group)

20 ml of ropivacaine 0.75%

DRUG

Intermittent boluses (Certa and standard catheter groups)

20 ml of ropivacaine 0.2% every 8 hour in the catheter

DRUG

Intermittent boluses (Single bolus group)

0.1ml of ropivacaine 0.2% every 8 hour in the sham catheter

Sponsors & Collaborators

  • University Hospital, Gentofte, Copenhagen

    lead OTHER

Principal Investigators

  • Ulrik Grevstad, MD, phd · Gentofte Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-09
Primary Completion
2018-04-12
Completion
2018-04-12

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03142789 on ClinicalTrials.gov